Ventriculo-arterial Coupling in Cirrhotics
NCT03948659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2019-05-14
Summary
Cirrhotic in intensive care unit have a very specific haemodynamic status. Cardiovascular abnormalities in advanced liver cirrhosis are characterized by a hyperdynamic circulation featuring increased heart rate and high cardiac output, concomitant with decreased systemic vascular resistance. As liver cirrhosis progresses, cardiac dysfunction, known as cirrhotic cardiomyopathy, is associated with prognosis of these patients.
Specifically, diastolic dysfunction has been more emphasized for estimating clinical outcome in cirrhotic patients, whereas systolic dysfunction has limited prognostic implications in hepatorenal syndrome patients.
However, in most cirrhotic patients, cardiac dysfunction is latent and only manifests under stressful conditions because reduced ventricular contractility in these patients is masked by pronounced arterial vasodilation and increased arterial compliance. Therefore, a load-dependent index such as left ventricular ejection fraction is insensitive to detect systolic cardiac impairment in the resting state in cirrhotic patients. Hence, a more appropriate index is required to evaluate the integration of the ventricular and arterial systems in cirrhotic cardiovascular disorders.
Interaction between the left ventricle and the arterial system has been explained on the basis of end-systolic pressure-volume relation. Left ventricular end-systolic elastance (Ees), as quantified by the ratio of end-systolic pressure to end-systolic volume, is an index of the load-independent ventricular contractile state. Given this pressure-volume relationship, effective arterial elastance (Ea) can be calculated by the ratio of end-systolic pressure to stroke volume, indicating a net measure of arterial load. The ratio of these values (Ea/Ees), designated ventriculo-arterial coupling (VAC), represents the integrated interaction of the ventricular and arterial systems.
We can evaluate it with non-invasive echocardiographic method.
We analyse VAC among cirrhotic patients admitted in intensive care unit, with non-invasive echographic method thanks to records made from August 2018 to April 2019.
Hypothesis: VAC decrease from the baseline value when mean arterial pressure is improved.
Conditions
- Cirrhosis
Interventions
- PROCEDURE
-
Arterio ventricular coupling
We analyse ventriculo arterial coupling (VAC) among cirrhotic patients admitted in intensive care unit, with non-invasive echography method
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-30
- Primary Completion
- 2019-04-30
- Completion
- 2019-04-30
Countries
- France
Study Locations
More Related Trials
-
To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites
NCT02649335 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.
NCT00968695 ·Status: COMPLETED ·Phase: PHASE4
-
Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.
NCT02467348 ·Status: COMPLETED ·Phase: NA
-
Acute-On-Chronic Liver Failure In Cirrhotic Patients
NCT04790435 ·Status: COMPLETED
-
Diagnosis of Variceal Bleeding and Its Control in Cirrhosis
NCT00188097 ·Status: TERMINATED ·Phase: NA
-
Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist
NCT03650660 ·Status: TERMINATED
-
Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis
NCT05596253 ·Status: RECRUITING
-
To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock
NCT02468063 ·Status: COMPLETED ·Phase: NA
-
To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.
NCT02467322 ·Status: COMPLETED ·Phase: NA
-
Microvesicles and Monocytes to Predict Mortality of Patients with Cirrhosis
NCT03837444 ·Status: COMPLETED
-
Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices
NCT02583698 ·Status: COMPLETED ·Phase: NA
-
Internal Jugular Vein Distensibility in Assessment of Fluid Responsiveness in Donors of Living Donor Liver Transplantation
NCT03391037 ·Status: COMPLETED
-
Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic
NCT03580577 ·Status: UNKNOWN
-
Home-based Bimodal Lifestyle Intervention in Patients With Liver Cirrhosis Awaiting Orthotopic Liver Transplantation
NCT05853484 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Optimized Remission in Alcohol-related Liver Cirrhosis
NCT06866496 ·Status: RECRUITING ·Phase: NA
-
Pattern and Short Term Outcomes of Renal Affection in Patients With Liver Cirrhosis in Al-Rajhi Liver Hospital
NCT06924294 ·Status: NOT_YET_RECRUITING
-
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"
NCT01201720 ·Status: COMPLETED ·Phase: NA
-
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study
NCT01091233 ·Status: WITHDRAWN
-
Incidence of Intracranial Hypertension During Liver Transplantation Estimated by Non-invasive Ultrasound Methods.
NCT02695823 ·Status: COMPLETED ·Phase: NA
-
Improving Performance of Paracentesis in Medical Residency Training
NCT01403987 ·Status: COMPLETED ·Phase: NA
-
Effect of Non-Selective Beta-Blockers on Outcomes in Cirrhosis Patients After Hospitalization: A Retrospective Cohort Using Target Trial Design
NCT06977685 ·Status: ACTIVE_NOT_RECRUITING
-
Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its Impact on Morbidity and Mortality
NCT02294292 ·Status: COMPLETED ·Phase: NA
-
Infections in Hospitalized Cirrhotic Patients
NCT03137719 ·Status: COMPLETED
-
Acute hemodynamiC Response To Carvedilol Predicts Survival in ACLF Patients
NCT06298656 ·Status: NOT_YET_RECRUITING
-
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414 ·Status: COMPLETED